Established in 2010 by well experienced scientists, AryoGen Pharmed pharmaceutical company has focused on providing biopharmaceutical products meeting world standards. The production facility is configured to manufacture some of the latest biopharmaceutical compounds to hit the local and international markets.
AryoGen is producing biosimilar or biogeneric form of some vital medicines that are critical for treatment of following diseases: Hemophilia A or B with inhibitors, Acquired hemophilia, Congenital, factor VII deficiency, Glanzmann’s thrombasthenia, Breast cancer, Rheumatoid Arthritis, Arthritis , Spondyloarthritis , Plaque Psoriasis , Juvenile Idiopathic, Non-Hodgkin's Lymphoma, Juvenile Idiopathic, Chronic Lymphocytic Leukemia (ccl).
Website: https://www.aryogen.com/
Email: contact@aryogen.com
Tel: +98 26 36106480-4
